FiercePharma ✓

@FiercePharma · West End, District of Columbia · joined 21 Dec 2008

Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.

100 753Followers

469Following

35 499Posts total

25.2KViews on collected posts

Against accounts of the same size

6 posts from the last 90 days, next to the 100K–1M follower range. shown widely, but few of those viewers react.

Median views4 231this account6 116median for 100K–1M

Reach, %4.20%this account2.57%median for 100K–1M

Engagement, %0.27%this account1.40%median for 100K–1M

Metric	This account	Median for 100K–1M	Ratio
Median views per post	4 231	6 116	0.69×
Reach (views ÷ followers)	4.20%	2.57%	1.63×
Engagement rate	0.27%	1.40%	0.19×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.7K27 Aug

3.7K28 Aug

4.8K1 Sep

5.4K

7.6K2 Sep

683 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%27 Aug

0.35%28 Aug

0.17%1 Sep

0.43%

0.18%2 Sep

0.00%3 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.40%.

What the audience does

Likes65.4%53 in total

Reposts13.6%11 in total

Replies6.2%5 in total

Quotes4.9%4 in total

Bookmarks9.9%8 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

@FiercePharma Strong early uptake shows the impact access and affordability can have on GLP-1 adoption. It will be interesting to see how this shapes patient demand and the broader obesity treatment market. 68 views · 0 likes · 0 reposts · 0 replies 03 Sep 2026 As part of the MFN drug pricing deal the Trump administration signed with obesity giants Eli Lilly and Novo Nordisk, Medicare recently launched a “bridge” model, offering weight loss drugs to eligible seniors at $50 per month. Now, we know the initial uptake from the program. 7.6K views · 9 likes · 2 reposts · 1 replies 02 Sep 2026 Congrats to Eric Topol, one of this year’s Fierce 50 Leadership honorees, recognized for decades of work advancing digital medicine and for helping define both the promise and limits of AI in healthcare. 5.4K views · 19 likes · 2 reposts · 2 replies 01 Sep 2026 The 2026 Fierce 50 is live. This year’s honorees include leaders, scientists, companies and organizations changing how drugs are developed, healthcare is delivered and patients navigate the system. Meet the Fierce 50: https://t.co/EL6VcAl3qq https://t.co/U3M1b03kgr 4.8K views · 4 likes · 2 reposts · 0 replies 01 Sep 2026 The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K https://t.co/sHrXXXhEpk 3.7K views · 10 likes · 2 reposts · 1 replies 28 Aug 2026 An inexperienced RevMed is now responsible for launching the most hotly anticipated cancer drug in years. https://t.co/vfyPNDK7uH 3.7K views · 11 likes · 3 reposts · 1 replies 27 Aug 2026